Dr. Jonathan Medenilla Zuniga, MD

Dr. Zuniga practices at Charleston Area Medical Center General Hospital in Charleston, West Virginia, part of Vandalia Health.

Dr. Zuniga's NPI, 1831167212, was assigned on March 10, 2006. Dr. Zuniga holds West Virginia license 20402.

Dr. Zuniga's primary practice is Charleston Area Medical Center General Hospital, at 501 Morris Street, Charleston, WV 25301 in Kanawha County. The practice phone is (304) 388-5432.

Dr. Zuniga's primary practice is Charleston Area Medical Center General Hospital in Charleston, West Virginia, part of Vandalia Health. Dr. Zuniga is also affiliated with Cabell Huntington Hospital. The medical group on file is Kidney Associates, PLLC. Dmand AI also links Dr. Zuniga to 3 more hospitals, 4 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zuniga practices, 10 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Zuniga's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Zuniga is licensed in West Virginia.

CMS data shows 3,673 Medicare services from Dr. Zuniga across 12 procedure codes in 2024, for 549 Medicare patients. Medicare paid $266,663 for them.

CMS counts 549 Medicare patients who saw Dr. Zuniga in 2024. The largest group is 75 to 84, with 188 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 21% are also on Medicaid. Their average risk score is 2.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zuniga's median patient age at 74, with 58% women.

In 2024, Dr. Zuniga wrote 2,760 Medicare Part D claims for 489 patients. 94% of them were for generic drugs. CMS names the drug for 2,623 of them, across 25 drugs with 11 or more claims each, at $198,039 in total drug cost. In 2023, CMS named 2,574 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Zuniga for performance year 2024, reported as part of a group. Dr. Zuniga accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zuniga as offering telehealth.

CMS Open Payments shows 13 general payments to Dr. Zuniga from 4 drug and device companies from 2022 to 2025. Education make up the largest share, 82% of the total. OPKO Pharmaceuticals, LLC paid the most, $116.